1. Machine learning in antiviral drug designAnja Kolarič, Marko Jukič, Urban Bren, 2026, review article Abstract: Viral infections pose a significant health threat worldwide. Due to the high mutation rates of many viruses and their reliance on host cellular machinery, the development of effective antiviral therapies is particularly difficult. As a result, only a limited number of antiviral agents is currently available. In parallel to modern vaccines, traditional antiviral drug development is both time-consuming and costly, underscoring the need for faster, more efficient approaches. In recent years, particularly since the beginning of the COVID-19 pandemic, machine learning (ML) together with broader artificial intelligence (AI), have emerged as powerful methodologies for drug discovery and offer the potential to accelerate the identification and development of antiviral agents. This review examines the application of ML in the early stages of antiviral drug discovery, with a particular focus on recent studies where ML methods have successfully identified hit compounds with experimentally demonstrated activity in biological assays. By highlighting these successful case studies, the review illustrates the growing impact of ML in advancing the discovery of urgently needed novel antivirals. Keywords: machine learning, artificial intelligence, antiviral compounds, biological activity Published in DKUM: 17.10.2025; Views: 0; Downloads: 4
Full text (10,88 MB) |
2. Unveiling polyphenol-protein interactions : a comprehensive computational analysisSamo Lešnik, Marko Jukič, Urban Bren, 2025, original scientific article Abstract: Our study investigates polyphenol-protein interactions, analyzing their structural diversity and dynamic behavior. Analysis of the entire Protein Data Bank reveals diverse polyphenolic structures, engaging in various noncovalent interactions with proteins. Interactions observed across crystal structures among diverse polyphenolic classes reveal similarities, underscoring consistent patterns across a spectrum of structural motifs. On the other hand, molecular dynamics (MD) simulations of polyphenol-protein complexes unveil dynamic binding patterns, highlighting the influx of water molecules into the binding site and underscoring limitations of static crystal structures. Water-mediated interactions emerge as crucial in polyphenol-protein binding, leading to variable binding patterns observed in MD simulations. Comparison of high- and low-resolution crystal structures as starting points for MD simulations demonstrates their robustness, exhibiting consistent dynamics regardless of the quality of the initial structural data. Additionally, the impact of glycosylation on polyphenol binding is explored, revealing its role in modulating interactions with proteins. In contrast to synthetic drugs, polyphenol binding seems to exhibit heightened flexibility, driven by dynamic water-mediated interactions, which may also facilitate their promiscuous binding. Comprehensive dynamic studies are, therefore essential to understand polyphenol-protein recognition mechanisms. Overall, our study provides novel insights into polyphenol-protein interactions, informing future research for harnessing polyphenolic therapeutic potential through rational drug design. Keywords: polyphenols, polyphenol-protein complexes, molecular dynamics simulations, noncovalent interactions, water-mediated interactions, glycosylation, dynamic behavior Published in DKUM: 14.08.2025; Views: 0; Downloads: 3
Full text (5,61 MB) |
3. Analiza glikoproteina (gp) virusa zaire ebolavirus ter identifikacija potencialnih terapevtskih tarč z orodji probis in cmdock : diplomsko delo univerzitetnega študijskega programa I. stopnjeAljoša Poš, 2025, undergraduate thesis Abstract: Zaire ebolavirus (EBOV) povzroča hemoragično mrzlico z visoko smrtnostjo in kljub napredku v medicinskih raziskavah še vedno nima odobrenega zdravila. V pričujočem diplomskem delu smo analizirali virusni glikoprotein (GP), ki ima osrednjo vlogo pri vstopu virusa v gostiteljske celice, z namenom identifikacije potencialnih zaviralcev. S pomočjo programske opreme ProBiS in PyMOL smo na osnovi strukturne podobnosti napovedali možna vezavna mesta na GP, ki bi lahko predstavljal terapevtsko tarčo. Na podlagi pregleda znanstvene literature smo oblikovali virtualno knjižnico malih molekul, ki smo jih nato z orodjem CmDock sidrali na izbrano, identificirano tarčno mesto. V nadaljevanju smo primerjali rezultate z digitalno knjižnico komercialno dostopnih spojin Enamin, pri čemer smo se osredotočili na analizo struktur spojin z najugodnejšimi ocenami sidranja. Izvedli smo kemoinformacijsko analizo strukturne podobnosti ter primerjavo osnovnih skeletov z znanimi zaviralci EBOV GP. Najobetavnejšim spojinam smo nato analizirali vezavne konformacije ter določili število in vrste nekovalentnih interakcij z GP. Ugotovili smo, da več spojin iz obeh knjižnic tvori potencialno stabilne komplekse z GP, pri čemer so nekatere spojine iz Enamin knjižnice po osnovni skeletni zgradbi presenetljivo podobne tistim iz naše strukturirane zbirke. Prav tako smo zaznali, da so nekatere spojine z najboljšimi CmDock ocenami sidranja kljub nizki Tanimotovi podobnosti vsebovale osnovne skeletne značilnosti že znanih zaviralcev. Slednje lahko uporabimo kot izhodišča za nadaljnje eksperimentalne raziskave na področju razvoja zaviralcev GP virusa EBOV. Keywords: Zaire ebolavirus, glikoprotein GP, zaviralci, vezavna mesta, molekulsko sidranje, strukturna podobnost Published in DKUM: 10.07.2025; Views: 0; Downloads: 44
Full text (8,96 MB) |
4. Synthesis, antimycobacterial activity, and computational insight of novel 1,4-benzoxazin-2-one derivatives as promising candidates against multidrug-resistant mycobacterium tuberculosisMaria Grazia Mamolo, Emanuele Carosati, Diletta Pasin, Alessandro De Logu, Gianluigi Cabiddu, Marko Jukič, Daniele Zampieri, 2025, original scientific article Abstract: In the search for new antitubercular agents, a series of 1,4-benzoxazinone-based compounds is designed, synthesized, and evaluated. These molecules show potent antimycobacterial activity, with a minimum inhibitory concentration between 2 and 8 μg mL−1. This interesting profile includes activity against several drug-resistant strains and minimal cytotoxicity against mammalian Vero cells. Structural similarities with analogs from the literature are reinforced by molecular docking and molecular dynamics simulations, suggesting that inhibition of the menaquinone-B enzyme as a potential mechanism of action. In addition, the active compounds exhibit favorable predicted Absorption, Distribuition, Metabolism, and Excretion (ADME) properties, indicating their potential for oral administration in humans. Keywords: antimycobacterial, benzoxazinones, cytotoxicities, dockings, menaquinone-B, minimum inhibitory concentrations Published in DKUM: 09.07.2025; Views: 0; Downloads: 5
Full text (1,77 MB) |
5. Novel small-molecule inhibitors of the SARS-CoV-2 spike protein binding to neuropilin 1Anja Kolarič, Marko Jukič, Urban Bren, 2022, original scientific article Abstract: Furin cleavage of the SARS-CoV-2 spike protein results in a polybasic terminal sequence
termed the C-end rule (CendR), which is responsible for the binding to neuropilin 1 (NRP1), enhancing
viral infectivity and entry into the cell. Here we report the identification of 20 small-molecule
inhibitors that emerged from a virtual screening of nearly 950,000 drug-like compounds that bind
with high probability to the CendR-binding pocket of NRP1. In a spike NRP1 binding assay, two of
these compounds displayed a stronger inhibition of spike protein binding to NRP1 than the known
NRP1 antagonist EG00229, for which the inhibition of the CendR peptide binding to NRP1 was
also experimentally confirmed. These compounds present a good starting point for the design of
small-molecule antagonists against the SARS-CoV-2 viral entry. Keywords: neuropilin 1, SARS-CoV-2, COVID-19, spike binding inhibitors, virtual screening, small-molecule antagonists, molecular docking, in vitro binding assay Published in DKUM: 09.05.2025; Views: 0; Downloads: 10
Full text (6,27 MB) This document has many files! More... |
6. Commercial SARS-CoV-2 targeted, protease inhibitor focused and protein–protein interaction inhibitor focused molecular libraries for virtual screening and drug designSebastjan Kralj, Marko Jukič, Urban Bren, 2022, review article Abstract: Since December 2019, the new SARS-CoV-2-related COVID-19 disease has caused a global
pandemic and shut down the public life worldwide. Several proteins have emerged as potential
therapeutic targets for drug development, and we sought out to review the commercially available
and marketed SARS-CoV-2-targeted libraries ready for high-throughput virtual screening (HTVS).
We evaluated the SARS-CoV-2-targeted, protease-inhibitor-focused and protein–protein-interactioninhibitor-focused libraries to gain a better understanding of how these libraries were designed. The
most common were ligand- and structure-based approaches, along with various filtering steps, using
molecular descriptors. Often, these methods were combined to obtain the final library. We recognized
the abundance of targeted libraries offered and complimented by the inclusion of analytical data;
however, serious concerns had to be raised. Namely, vendors lack the information on the library
design and the references to the primary literature. Few references to active compounds were also
provided when using the ligand-based design and usually only protein classes or a general panel
of targets were listed, along with a general reference to the methods, such as molecular docking for
the structure-based design. No receptor data, docking protocols or even references to the applied
molecular docking software (or other HTVS software), and no pharmacophore or filter design
details were given. No detailed functional group or chemical space analyses were reported, and no
specific orientation of the libraries toward the design of covalent or noncovalent inhibitors could
be observed. All libraries contained pan-assay interference compounds (PAINS), rapid elimination
of swill compounds (REOS) and aggregators, as well as focused on the drug-like model, with the
majority of compounds possessing their molecular mass around 500 g/mol. These facts do not bode
well for the use of the reviewed libraries in drug design and lend themselves to commercial drug
companies to focus on and improve. Keywords: targeted libraries, focused libraries, computer-aided drug design, virtual screening, in silico drug design, high-throughput virtual screening Published in DKUM: 09.04.2025; Views: 0; Downloads: 7
Full text (6,53 MB) This document has many files! More... |
7. Identification of furin protease small-molecule inhibitor with a 1,3-thiazol-2-ylaminosulfonyl scaffoldAnja Kolarič, Vid Ravnik, Sara Štumpf Horvat, Marko Jukič, Urban Bren, 2025, original scientific article Keywords: computer-assisted drug design, CADD, computer-assisted drug design, furin inhibitors, protease inhibitors, antivirals, protease inhibitors, furin assay, antiviral drug design Published in DKUM: 20.03.2025; Views: 0; Downloads: 3
Full text (6,26 MB) |
8. Študija in optimizacija vezave antikalinov na male molekule : diplomsko delo univerzitetnega študijskega programa I. stopnjeAlja Špec, 2024, undergraduate thesis Abstract: V diplomskem delu smo raziskovali optimizacijo vezave anitkalina na majhno molekulo s tehniko molekulskega sidranja in in silico mutageneze. Osredotočili smo se na razumevanje, kako lahko specifične mutacije aminokislin znotraj antikalina vplivajo na njegove interakcije z različnimi ligandi. Pri tem smo s programskim jezikom Python pripravili skripto, ki nam je pomagala pri izvedbi in silico mutageneze aminokislinskih ostankov in oceno vezave med proteinom in ligandom. Rezultati so pokazali potencialno ugodne mutacije, ki bi lahko povečale vezavno afiniteto liganda. Tako smo pokazali enostavni postopek, s katerim lahko optimiziramo vezavo testnih ligandov na antikaline in s tem skrajšamo in vitro postopke oz. efektivneje izvajamo laboratorijsko delo. Ugotovitve diplomske naloge pa prispevajo tudi dragocen vpogled v podrobnosti interakcij ligand-protein, saj lahko vezavno mesto antikalinov omogoči visoko selektivnost za vezavo preučevanih malih molekul. Keywords: in silico mutageneza, antikalini, molekulsko sidranje, lipokalinske strukture, vezavno mesto Published in DKUM: 15.07.2024; Views: 132; Downloads: 73
Full text (1,95 MB) |
9. Primerjava proteomov glavnih predstavnikov virusov iz družine Filoviridae in identifikacija potencialnih vezavnih mest za načrtovanje ligandov : magistrsko deloKatja Gole, 2024, master's thesis Abstract: Virus Ebola Zaire (EBOV) in virus Marburg Marburg (MARV) sta glavna predstavnika družine Filoviridae, ki pri ljudeh povzročata hudo virusno hemoragično mrzlico, s stopnjo smrtnosti do 90 %. Kljub temu je zaradi le občasnih izbruhov bolezni, ki jih ni možno predvideti, razvoj zdravil okrnjen in se izvaja predvsem v akademskih krogih. V magistrskem delu smo preverjali podobnost virusnih proteomov in vezavnih mest z namenom, da bi v prihodnje bilo možno načrtovati učinkovine, ki bi se lahko vezale na terapevtske tarče obeh virusov. EBOV in MARV kodirata enakih sedem proteinov, in sicer NP, VP35, VP40, GP, VP30, VP24 in L protein, ki imajo glede na informacije, ki smo jih pridobili s pomočjo podatkovnih zbirk UniProt in PDB, podobne funkcije in zgradbo. Podobnost proteomov smo potrdili še z BLAST analizo aminokislinskih sekvenc med posameznimi proteini obeh virusov, pri čemer se podobnost proteinov giblje med 44 in 55 %, oziroma 68 % v 1. delu sekvence L proteinov. S programom ProBiS smo glede na primerjavo z že znanimi strukturami podobnih proteinov določili potencialna vezavna mesta in pripadajoče potencialne ligande. Vezavna mesta smo opisali in jih primerjali s pomočjo superpozicije proteinov obeh virusov. Kot rezultat smo pridobili tri pare podobnih vezavnih mest, ki se kljub podobnosti razlikujejo v posameznih aminokislinah, kar smo dokazali z BLAST primerjavo. S PLIP analizo smo pokazali, da aminokislinski ostanki v vezavnem mestu posameznega virusa tvorijo podobne interakcije z enakimi ligandi in da s tem obstaja možnost načrtovanja terapevtikov, ki bi se hkrati vezali na tarče EBOV in MARV. Keywords: Ebola, Marburg, BLAST, vezavna mesta, ProBiS, načrtovanje ligandov Published in DKUM: 11.07.2024; Views: 104; Downloads: 36
Full text (15,22 MB) |
10. Molecular Filters in Medicinal ChemistrySebastjan Kralj, Marko Jukič, Urban Bren, 2023, review article Keywords: medicinal chemistry, filtering chemical libraries, chemical space, HTVS, virtual screening, computer aided drug-design, in silico drug design, bioinformatics, chemoinformatic, compound library Published in DKUM: 20.05.2024; Views: 168; Downloads: 26
Full text (1,66 MB) This document has many files! More... |